Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
AHA 2019: Colchicine in Percutaneous Coronary Intervention (PCI)
Author(s): Binita Shah Added: 4 years ago
Dr Binita Shah (NYU Langone Health, New York, NY, US) discusses Colchicine in Percutaneous Coronary Intervention (PCI). Questions: 1.What is colchicine and why study it in PCI? 2.What was the study design, patient population and primary and secondary outcomes? 3.What were your outcomes? 4.How do these compare to those in the COLCOT study? 5.How should your study be interpreted in clinical… View more

Intervention
Added: 3 years ago Source:  BUSINESS WIRE
Miracor UK Ltd to open Sales and Education Center in Manchester Science Parks VIENNA, Austria--Miracor Medical Systems announced today that it will further increase its activities in the UK, led by its newly founded sales subsidiary in Manchester. To date, several leading centers in the UK are already actively using the PICSO Impulse System to treat patients with myocardial infarction (MI). “We… View more
Job title: Professor of Cardiovascular Medicine
ProfKeith Channonis the Chief Investigator of OxAMI. He is Professor of Cardiovascular Medicine at Oxford University and an Interventional Cardiologist at the John Radcliffe Hospital. He has extensive experience in Percutaneous Coronary Intervention (PCI ) and intravascular imaging and in atherosclerotic plaque and vascular biology. Prof Channon is Director of R&D at Oxford University… View more
Job title: Senior Clinical Lecturer in Cardiology
Dr Paul Morris is aSenior Clinical Lecturer in Cardiology at theUniversity of Sheffieldand Honorary Cardiology Consultant at Sheffield Teaching Hospitals. Dr Morris is also Director for Clinical Translation at the Insigneo Institute for In Silico Medicine. As an interventional cardiologist, his areas of clinical interest include percutaneous coronary intervention (PCI) and coronary… View more
ACC 2021: The Tailor-PCI Follow-up Study
Author(s): Naveen Pereira Added: 2 years ago
Dr Naveen Pereira (Mayo Clinic College of Medicine, Rochester, MN) discusses the findings of the Tailor-PCI follow-up study, which evaluated the effect of oral P2y12 inhibitors vs clopidogrel after percutaneous coronary intervention (PCI). Questions: 1. Can briefly remind us of the Tailor-PCI RCT? 2. What does a point-of-care genotype test look like? 3. What was the aim of the follow-up study? 4… View more

Anticoagulation

Intervention
Dr Duncan Hogg, gained his medical qualification at the University of Aberdeen in 1994. In 1997 he became a Member of the Royal College of Physicians. Dr Hogg received his general cardiology training at Aberdeen Royal Infirmary and completed specialist training in Cardiology & General Internal Medicine (GIM) in 2007. Dr Hogg has Specialist Registration with the General Medical Council for… View more
SYNTAX II Trial: 5yr Data Shows Reduction in MACE in PCI
Author(s): Adrian P Banning Added: 2 years ago
In this interview, Professor Adrian Banning (John Radcliffe Hospital, Oxford, UK) discusses the five-year outcomes of the SYNTAX II trial. This study aims to evaluate the impact of new technologies in percutaneous coronary intervention (PCI) by comparing the outcomes of these procedures to the original SYNTAX trial. The study showed that PCI moved forward considerably in the last 5 years, it is… View more

Intervention
Ventricular Assist Device - ABIOMED, Inc.
Abiomed: Manufacturer of Impella®Percutaneous Ventricular Assist Device Abiomed, founded in 1981, is a global pioneer in healthcare technology, with a mission to recover hearts and save lives. From the World’s first total replacement heart pump to the World’s smallest heart pump, Abiomed has developed a family of ventricular assist devices (VAD), namely the Impella® platform of percutaneous… View more
CardioNerds @AHA23: ORBITA-2: PCI for Stable Angina
Author(s): Rasha Al-Lamee , Christopher Rajkumar , Nazli Okumus Added: 5 months ago
AHA 2023 — Investigators of ORBITA-2 trial, Dr Rasha Al-Lamee and Dr Christopher Rajkumar (Imperial College London, UK) talked with CardioNerds Ambassador, Dr Nazli Okumus about the randomised, placebo-controlled trial (NCT03742050) that compared the effects of coronary angioplasty versus placebo procedure on symptoms of stable angina without background anti-anginal therapy at 12 weeks.The ORBITA… View more

Intervention